FDA Updates Convalescent Plasma Guidelines to Announce Temporary Enforcement Discretion for Testing
Four key points from the FDA’s September 2020 update to initial COVID-19 convalescent plasma guidelines.
Day: September 11, 2020
COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Menu
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.